Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20Â mg plus ezetimibe 10Â mg vs. simvastatin 40 or 80Â mg plus ezetimibe 10Â mg in high-risk patients: Results of the GRAVITY randomized stud

Co-administration of rosuvastatin 10 or 20 mg plus ezetimibe achieved significant improvements in lipid profiles in high-risk patients vs. simvastatin 40 or 80 mg plus ezetimibe.